Hypertension may increase risk for developing glaucoma
the ONA take:
According to a new study published in the journal Investigative Ophthalmology and Visual Science, chronic hypertension may increase a person's risk for developing glaucoma.
For the study, researchers from the department of optometry and vision sciences at the University of Melbourne in Melbourne, Australia, raised the blood pressure of rats either for 1 hour (short-term hypertension) or for 4 weeks (long-term hypertension).
When the researchers raised the blood pressure for just 1 hour, eye pressure did not increase, but when their blood pressures were elevated for 4 weeks, the researchers found an increase in eye pressure, suggesting that chronic hypertension increases the risk of glaucoma.
It had previously been thought that hypertension counteracts the eye pressure elevation that ultimately causes glaucoma, but this research indicates that chronic hypertension might damage the ophthalmic blood vessels so that the blood vessels cannot compensate for blood flow changes caused by eye pressure elevation.
The researchers note that further research is warranted to better understand the best approach to treat patients with hypertension who also develop glaucoma, but now, clinicians should regard hypertension as a risk factor for glaucoma.
Chronic hypertension may increase a person's risk for developing glaucoma.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|